ERICA BINDRIM: Open Payments
NPI 1437392347 · WARRENTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$814 in 42 payments from 13 companies in 2025. Trend: 2023 $812 · 2024 $621 · 2025 $814
Food & beverage: $814
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $117 |
| Axsome Therapeutics, Inc. | 6 | $116 |
| Alkermes, Inc. | 6 | $111 |
| Vanda Pharmaceuticals Inc. | 4 | $94 |
| Lundbeck LLC | 4 | $65 |
| Collegium Pharmaceutical, Inc. | 3 | $57 |
| Corium, LLC | 3 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
| Tris Pharma Inc | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
Products named: REXULTI, Auvelity, ARISTADA, FANAPT, Jornay PM, Azstarys, TRINTELLIX, Dyanavel XR.
Industry payments across VA — which companies pay providers there.
